Market News & Trends
Pfizer CentreOne Expands Fill-Finish Services
Pfizer CentreOne, a global contract manufacturing organization embedded within Pfizer, recently announced that it has expanded its fill-finish services to its Kalamazoo, MI, site. Along…
MedCrypt & QuiO Partner on Device Security for Safe Transfer of Prescriptions & Injection Data
MedCrypt, an early stage medical device software security company, and QuiO, an early stage connected therapeutics company, recently announced an integration partnership for the Smartinjector…
GW Pharmaceuticals Achieves Positive Results in Phase II Study
GW Pharmaceuticals plc recently announced positive top-line results from an exploratory Phase II placebo-controlled clinical study of a proprietary combination of tetrahydrocannabinol (THC) and cannabidiol…
Galectin Presents Clinical Data of Combination Immunotherapy With Galectin-3 Inhibitor GR-MD-02
Galectin Therapeutics Inc. and the Providence Cancer Center recently announced the presentation of preclinical and early clinical data from two investigator-initiated Phase I clinical trials…
Metrics Contract Services: Your "Concept to Commercialization" Partner
The parent company of Metrics Contract Services, Mayne Pharma, is investing $80 million to significantly expand facilities and equipment at its site in Greenville, N.C.…
Q BioMed, Oklahoma Medical Research & Rajiv Gandhi Centre to Develop Chemotherapeutic Technology
Q BioMed, Inc. has entered into an agreement with the Oklahoma Medical Research Foundation (OMRF) and the Rajiv Gandhi Centre for Biotechnology (RGCB) to develop…
Lupus R&D Landscape Set to be Dominated by Big Pharma & Small Biotech Partnerships
The lupus market, which is set to reach $3.2 billion by 2025 and has historically been dominated by inexpensive generic drugs, will see a future…
Metrics Contract Services: Your "Concept to Commercialization" Partner
The parent company of Metrics Contract Services, Mayne Pharma, is investing $80 million to significantly expand facilities and equipment at its site in Greenville, N.C.…
Foster Delivery Science & ProMed Pharma Partner
Foster Delivery Science and ProMed Pharma have entered into a commercial partnership to provide comprehensive contract services for pharmaceutical and combination device applications. Jointly, the…
Pharma & Biotech: 2017 Review of Outsourced Manufacturing
Foreword I am pleased to introduce you to our 2017 review of the outsourced manufacturing sector, where we share some of the trends…
Foster Delivery Science & ProMed Pharma Partner
Foster Delivery Science and ProMed Pharma have entered into a commercial partnership to provide comprehensive contract services for pharmaceutical and combination device applications. Jointly, the…
Pharma & Biotech: 2017 Review of Outsourced Manufacturing
Foreword I am pleased to introduce you to our 2017 review of the outsourced manufacturing sector, where we share some of the trends…
Next-Generation Silicone Adhesive Technologies Key to Broader Global Adoption, Growth of Wearable Medical Devices
According to Grand View Research, the global market for wearable medical devices is expected to reach $27.8 billion by 2022.1 Dow Corning, a global leader…
Advaxis’ GOG-0265 Study in Metastatic Cervical Cancer Selected for Late-Breaking Data Presentation
Advaxis, Inc. recently announced that an abstract on data from the company’s Phase II GOG-0265 trial evaluating axalimogene filolisbac for metastatic cervical cancer has been…
Gerresheimer Optimizes Cold-End Operations at its Pharma Glass Production Plants With State-of-the-Art Packing Robots
Every year, Gerresheimer’s pharmaceutical industry customers order several hundreds of millions of glass pharmaceutical packaging products manufactured at the company’s plants in Essen and Lohr.…
Incyte & Calithera Biosciences Announce Global Collaboration
Incyte Corporation and Calithera Biosciences, Inc. recently announced the companies have entered into a global collaboration and license agreement for the research, development, and commercialization…
Gemphire Announces Interim LDL-C Lowering Data From Clinical Trial
Gemphire Therapeutics Inc. recently announced interim data on the LDL-C primary endpoint from the ongoing open label COBALT-1 trial. COBALT-1 is investigating gemcabene in homozygous familial…
First Clinical Milestone Achieved in Collaboration Between AbCheck & Lilly
AbCheck s.r.o., a technology company focusing on the discovery and optimization of high-quality human antibodies, recently announced the achievement of the first clinical milestone in…
Abeona Therapeutics Enrolls First High-Dose Subject in Ongoing Phase I/II Trial
Abeona Therapeutics Inc. recently announced that the first high-dose subject was enrolled in the ongoing Phase I/II trial for ABO-102 (AAV-SGSH). The first-in-man clinical trial…
SiO2 Medical Products, Inc. Receives Marketing Authorization for Filled 6-mL Vials
SiO2 Medical Products, Inc. (SMP) received marketing authorization (MA) for the Type II variation of the primary packaging of zoledronic acid from the German Medicines…
